In HNSCC and lung SCC, genomic amplification of the TP63 locus has been reported in up to 10% and 16% of the cases, respectively (Cancer Genome Atlas Network 2015; Cancer Genome Atlas Research Network, 2012; Pickering et al., 2013). This evidence concerns the gene TP63 and head and neck squamous cell carcinoma.